Applied Genetic Technologies Corporation
Applied Genetic Technologies Corporation (AGTC) Revenue
Annual & quarterly revenue history · segment & region breakdown
AGTC · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsApplied Genetic Technologies Corporation trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Applied Genetic Technologies Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Applied Genetic Technologies Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Applied Genetic Technologies Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
AGTC revenue · 4 questionsAGTC's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Applied Genetic Technologies Corporation SEC filings · GAAP · Applied Genetic Technologies Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026